Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9817472 | 0.95 | GPR84 (0.38) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL6131046 | 0.92 | GPR84 (0.48) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL13176588 | 0.90 | GPR84 (0.52) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL6279143 | 0.90 | GPR84 (0.52) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL16074884 | 0.90 | GPR84 (0.52) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL1047391 | 0.90 | GPR84 (0.52) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL16074779 | 0.90 | GPR84 (0.52) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL16074736 | 0.90 | GPR84 (0.52) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL16074931 | 0.90 | GPR84 (0.52) | GPR84FFAR4FFAR1PSMD14PLA2G1B | |
| SCHEMBL14006048 | 0.90 | GPR84 (0.52) | GPR84FFAR4FFAR1PSMD14PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250040541-A1 | AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2025-02-06 | — | — | US | claimed |
| EP-4451875-A1 | AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2024-10-30 | — | — | EP | claimed |
| WO-2023122003-A1 | AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2023-06-29 | — | — | WO | claimed |
| US-20230147032-A1 | PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS | HERAEUS EPURIO GMBH (DE) | 2023-05-11 | — | — | US | claimed |
| WO-2021198214-A2 | PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS | Heraeus Deutschland GmbH & Co. KG (DE) | 2021-10-07 | — | — | WO | claimed |
| EP-3889980-A1 | PROCESS FOR PRODUCING POLYMER CAPACITORS FOR HIGH RELIABILITY APPLICATIONS | Heraeus Deutschland GmbH & Co KG (DE) | 2021-10-06 | — | — | EP | claimed |
| WO-2017143132-A1 | ALKYL DIOLS FOR CRUDE OIL TREATMENT | ECOLAB USA INC. (US) | 2017-08-24 | — | — | WO | claimed |
| US-20170233666-A1 | ALKYL DIOLS FOR CRUDE OIL TREATMENT | APERGY BMCS ACQUISITION CORP | 2017-08-17 | — | — | US | claimed |
| US-20160040029-A1 | PHOTO-RESPONSIVE HYDROPHILIC COATING | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2016-02-11 | — | — | US | claimed |
| EP-2981591-A2 | PHOTO-RESPONSIVE HYDROPHILIC COATING | Empire Technology Development LLC (US) | 2016-02-10 | — | — | EP | claimed |
| US-5851962-A | Lubricant composition for wet clutch or wet brake | ETHYL JAPAN CORPORATION (JP) | 1998-12-22 | — | — | US | claimed |
| CN-1196081-A | Concentrated, water dispersible, stable, fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-14 | — | — | CN | claimed |
| CN-1195369-A | Concentrated and stable fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-07 | — | — | CN | claimed |
| EP-0842250-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | claimed |
| EP-0839179-A1 | CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-06 | — | — | EP | claimed |
| US-5747443-A | BIODEGRADABLE QUATERNARY AMMONIUM COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-05 | — | — | US | claimed |
| WO-1998017756-A1 | CONCENTRATED FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-30 | — | — | WO | claimed |
| WO-1997003170-A1 | CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | claimed |
| WO-1997003169-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | claimed |
| US-4092359-A | Process for the preparation of 2,5-dideoxystreptamine and of a novel intermediate therefor | SCHERING CORPORATION (US) | 1978-05-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250040541-A1 | AN ANTIMICROBIAL LIQUID COMPOSITION, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | RASGRP3, RSU1, RPP30 | GPR84 4302/4885FFAR4 3619/4885FFAR1 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.